Judah Frommer
Stock Analyst at Morgan Stanley
(4.03)
# 1,746
Out of 4,634 analysts
475
Total ratings
55.5%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LKFT Lakefront Biotherapeutics NV | Rated: Hold | $30 → $26 | $27.64 | -5.93% | 53 | Aug 11, 2026 | |
| PROK ProKidney | Maintained: Hold | $3 | $1.56 | +92.93% | 15 | Aug 11, 2026 | |
| IMMX Immix Biopharma | Rated: Buy | $20 → $19 | $10.08 | +88.49% | 2 | Aug 11, 2026 | |
| TRVI Trevi Therapeutics | Rated: Buy | $20 → $23 | $18.23 | +26.17% | 7 | Aug 10, 2026 | |
| EVMN Evommune | Rated: Buy | $26 | $13.80 | +88.41% | 9 | Aug 10, 2026 | |
| AGMB AgomAb Therapeutics NV | Rated: Buy | $28 | $15.00 | +86.67% | 6 | Aug 10, 2026 | |
| CLDX Celldex Therapeutics | Rated: Buy | $40 → $46 | $42.48 | +8.29% | 11 | Aug 7, 2026 | |
| RGNX REGENXBIO | Rated: Buy | $16 → $18 | $10.21 | +76.38% | 21 | Aug 7, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Hold | kr 226.60 | kr 1,977 | -88.54% | 1 | Aug 7, 2026 | |
| GMAB Genmab | Rated: Hold | $33 → $35 | $30.77 | +13.75% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $38 | $26.05 | +45.87% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $119 → $135 | $108.02 | +24.98% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $18 | $13.60 | +32.35% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $104 | $75.00 | +38.67% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $119 | $121.32 | -1.91% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $132 → $180 | $129.12 | +39.41% | 7 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.94 | +255.33% | 3 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.15 | - | 13 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.79 | - | 9 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $34.56 | +53.36% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $31.12 | -29.31% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $25.74 | +43.75% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $191 → $201 | $170.00 | +18.24% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $141 → $139 | $17.66 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $0.0002 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.72 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.835 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $7.25 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $31.81 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $27.85 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $10.60 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $2.43 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.72 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $55 | $45.92 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $132.88 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.5 | $31.97 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $109.58 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $85.55 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $12.29 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $79.32 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $328 | $953.75 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $56.72 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $231.00 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 → €24.00 | €32.31 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $128.99 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $154 → $178 | $121.98 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $96.10 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $84.11 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $113.29 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $18.90 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $38.48 | n/a | 1 | Mar 6, 2019 |
Lakefront Biotherapeutics NV
Aug 11, 2026
Rated: Hold
Price Target: $30 → $26
Current: $27.64
Upside: -5.93%
ProKidney
Aug 11, 2026
Maintained: Hold
Price Target: $3
Current: $1.56
Upside: +92.93%
Immix Biopharma
Aug 11, 2026
Rated: Buy
Price Target: $20 → $19
Current: $10.08
Upside: +88.49%
Trevi Therapeutics
Aug 10, 2026
Rated: Buy
Price Target: $20 → $23
Current: $18.23
Upside: +26.17%
Evommune
Aug 10, 2026
Rated: Buy
Price Target: $26
Current: $13.80
Upside: +88.41%
AgomAb Therapeutics NV
Aug 10, 2026
Rated: Buy
Price Target: $28
Current: $15.00
Upside: +86.67%
Celldex Therapeutics
Aug 7, 2026
Rated: Buy
Price Target: $40 → $46
Current: $42.48
Upside: +8.29%
REGENXBIO
Aug 7, 2026
Rated: Buy
Price Target: $16 → $18
Current: $10.21
Upside: +76.38%
Genmab A/S
Aug 7, 2026
Maintained: Hold
Price Target: kr 226.60
Current: kr 1,977
Upside: -88.54%
Genmab
Aug 7, 2026
Rated: Hold
Price Target: $33 → $35
Current: $30.77
Upside: +13.75%
Aug 6, 2026
Rated: Buy
Price Target: $34 → $38
Current: $26.05
Upside: +45.87%
Aug 6, 2026
Rated: Buy
Price Target: $119 → $135
Current: $108.02
Upside: +24.98%
Aug 6, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $13.60
Upside: +32.35%
Jul 31, 2026
Maintained: Buy
Price Target: $93 → $104
Current: $75.00
Upside: +38.67%
Jul 29, 2026
Maintained: Hold
Price Target: $104 → $119
Current: $121.32
Upside: -1.91%
Jul 24, 2026
Rated: Buy
Price Target: $132 → $180
Current: $129.12
Upside: +39.41%
Jul 17, 2026
Maintained: Buy
Price Target: $14
Current: $3.94
Upside: +255.33%
Jun 29, 2026
Maintained: Hold
Price Target: n/a
Current: $11.15
Upside: -
Jun 18, 2026
Downgraded: Sell
Price Target: n/a
Current: $1.79
Upside: -
Jun 3, 2026
Maintained: Buy
Price Target: $53
Current: $34.56
Upside: +53.36%
May 14, 2026
Maintained: Hold
Price Target: $21 → $22
Current: $31.12
Upside: -29.31%
May 12, 2026
Rated: Buy
Price Target: $36 → $37
Current: $25.74
Upside: +43.75%
Mar 3, 2026
Maintained: Buy
Price Target: $191 → $201
Current: $170.00
Upside: +18.24%
Aug 3, 2023
Maintained: Hold
Price Target: $141 → $139
Current: $17.66
Upside: n/a
Jun 5, 2023
Maintained: Buy
Price Target: $138
Current: $0.0002
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $5.72
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.835
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $9
Current: $7.25
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $31.81
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $21 → $22
Current: $27.85
Upside: n/a
Mar 31, 2023
Maintained: Buy
Price Target: $8 → $7
Current: $10.60
Upside: n/a
Mar 28, 2023
Maintained: Buy
Price Target: $16 → $13
Current: $2.43
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.72
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $51 → $55
Current: $45.92
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $132.88
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $3.5
Current: $31.97
Upside: n/a
Aug 4, 2020
Maintained: Buy
Price Target: $23 → $24
Current: $109.58
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $22 → $26
Current: $85.55
Upside: n/a
Jul 27, 2020
Maintained: Buy
Price Target: $18
Current: $12.29
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $79.32
Upside: n/a
Jul 8, 2020
Maintained: Hold
Price Target: $328
Current: $953.75
Upside: n/a
Jun 18, 2020
Maintained: Hold
Price Target: $35
Current: $56.72
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $231.00
Upside: n/a
Jun 3, 2020
Maintained: Hold
Price Target: €22.00 → €24.00
Current: €32.31
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $128.99
Upside: n/a
May 22, 2020
Maintained: Hold
Price Target: $154 → $178
Current: $121.98
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $96.10
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $84.11
Upside: n/a
May 4, 2020
Maintained: Buy
Price Target: $39
Current: $113.29
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $18.90
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $38.48
Upside: n/a